Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tagliati

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
AJNR. American Journal of Neuroradiology|October 8, 1999
MR findings in AIDS-associated myelopathyJ Chong, A Di Rocco, M Tagliati, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 29, 1999
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterationsP Stanzione, I Bodis-Wollner, M Pierantozzi, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1990
Dopaminergic pharmacological manipulations in normal humans confirm the specificity of the visual (PERG-VEP) and cognitive (P300) electrophysiological alterations in Parkinson's diseaseP Stanzione, F Fattapposta, M Tagliati, et al.
Electroencephalography and Clinical Neurophysiology|June 1, 1992
Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's diseaseA Peppe, P Stanzione, F Pierelli, et al.
Neurology|August 19, 2007
Sixty hertz pallidal deep brain stimulation for primary torsion dystoniaR L Alterman, J Miravite, D Weisz, et al.
Vision Research|September 1, 1995
Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogramP Stanzione, M Pierantozzi, R Semprini, et al.
Neurology|August 10, 2000
AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluidA Geraci, A Di Rocco, M Liu, et al.
Neurology|October 13, 2004
Treatment of AIDS-associated myelopathy with L-methionine: a placebo-controlled studyA Di Rocco, P Werner, T Bottiglieri, et al.
European Journal of Neurology|February 25, 2009
Subthalamic deep brain stimulation and impulse control in Parkinson's diseaseT D Hälbig, W Tse, P G Frisina, et al.
Neurology|May 1, 1996
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trialD M Simpson, D N Alexander, C F O'Brien, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
AJNR. American Journal of Neuroradiology|October 8, 1999
MR findings in AIDS-associated myelopathyJ Chong, A Di Rocco, M Tagliati, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 29, 1999
A mixed D1 and D2 antagonist does not replay pattern electroretinogram alterations observed with a selective D2 antagonist in normal humans: relationship with Parkinson's disease pattern electroretinogram alterationsP Stanzione, I Bodis-Wollner, M Pierantozzi, et al.
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1990
Dopaminergic pharmacological manipulations in normal humans confirm the specificity of the visual (PERG-VEP) and cognitive (P300) electrophysiological alterations in Parkinson's diseaseP Stanzione, F Fattapposta, M Tagliati, et al.
Electroencephalography and Clinical Neurophysiology|June 1, 1992
Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's diseaseA Peppe, P Stanzione, F Pierelli, et al.
Neurology|August 19, 2007
Sixty hertz pallidal deep brain stimulation for primary torsion dystoniaR L Alterman, J Miravite, D Weisz, et al.
Vision Research|September 1, 1995
Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogramP Stanzione, M Pierantozzi, R Semprini, et al.
Neurology|August 10, 2000
AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluidA Geraci, A Di Rocco, M Liu, et al.
Neurology|October 13, 2004
Treatment of AIDS-associated myelopathy with L-methionine: a placebo-controlled studyA Di Rocco, P Werner, T Bottiglieri, et al.
European Journal of Neurology|February 25, 2009
Subthalamic deep brain stimulation and impulse control in Parkinson's diseaseT D Hälbig, W Tse, P G Frisina, et al.
Neurology|May 1, 1996
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trialD M Simpson, D N Alexander, C F O'Brien, et al.
Pageof 5